- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The challenges of clinical trials in fragile X syndrome ; volume:231 ; number:6 ; day:31 ; month:10 ; year:2013 ; pages:1237-1250 ; date:3.2014
Psychopharmacology ; 231, Heft 6 (31.10.2013), 1237-1250, 3.2014
- Creator
-
Jacquemont, Sébastien
Berry-Kravis, Elizabeth
Hagerman, Randi
Raison, Florian von
Gasparini, Fabrizio
Apostol, George
Ufer, Mike
Portes, Vincent Des
Gomez-Mancilla, Baltazar
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-013-3289-0
- URN
-
urn:nbn:de:101:1-2019090122415466176864
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jacquemont, Sébastien
- Berry-Kravis, Elizabeth
- Hagerman, Randi
- Raison, Florian von
- Gasparini, Fabrizio
- Apostol, George
- Ufer, Mike
- Portes, Vincent Des
- Gomez-Mancilla, Baltazar
- SpringerLink (Online service)
Other Objects (12)
Arbaclofen in fragile X syndrome: results of phase 3 trials
Modeling fragile X syndrome
Fragile X syndrome: a review of clinical and molecular diagnoses
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
Aging in fragile X syndrome
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
Developmental studies in fragile X syndrome
Targeted treatments for fragile X syndrome
Challenges in launching multinational oncology clinical trials in India
Progress in Rett Syndrome: from discovery to clinical trials
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
Experiences and challenges with the new European Clinical Trials Regulation
Arbaclofen in fragile X syndrome: results of phase 3 trials
Modeling fragile X syndrome
Fragile X syndrome: a review of clinical and molecular diagnoses
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
Aging in fragile X syndrome
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
Developmental studies in fragile X syndrome
Targeted treatments for fragile X syndrome
Challenges in launching multinational oncology clinical trials in India
Progress in Rett Syndrome: from discovery to clinical trials
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
Experiences and challenges with the new European Clinical Trials Regulation
Arbaclofen in fragile X syndrome: results of phase 3 trials
Modeling fragile X syndrome
Fragile X syndrome: a review of clinical and molecular diagnoses
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
Aging in fragile X syndrome
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
Developmental studies in fragile X syndrome
Targeted treatments for fragile X syndrome
Challenges in launching multinational oncology clinical trials in India
Progress in Rett Syndrome: from discovery to clinical trials
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents